Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...

A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for ...

With the backing of Rishi Sunak, Prostate Cancer Research, has published a report to the National Screening Committee in 2022 in support of a targeted program for men at ‘high risk’. So, who are they ...

The effectiveness of the Interaktor app was evaluated in a randomized trial of patients undergoing radiotherapy for prostate cancer monitor and manage their symptoms.

New research indicates that high levels of folate and vitamin B12 may elevate prostate cancer risk, particularly for ...

Prostate cancer patients who closely follow ACS guidelines after diagnosis have lower all-cause and cardiovascular mortality than those who do not.

Scientists have found a key weakness in prostate cancer cells. Two enzymes, PDIA1 and PDIA5, help cancer cells survive and ...

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling ...

Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.

A double-pronged attack on advanced prostate cancer could help treat as many as two in five patients with late-stage disease, ...